|
EVAX Evaxion Biotech As 1828253 |
| Income Statement |
|
Revenue
|
f6k_030425
|
154,000 |
|
Net Income
|
f6k_030425
|
-6,198,000 |
|
Profit Margin
|
|
-4024.68% |
| Balance Sheet |
|
Current Assets
|
10,700,000 |
|
Assets
|
15,231,000 |
|
Current Liabilities
|
3,821,000 |
|
Liabilities
|
13,978,000 |
|
Equity
|
1,253,000 |
|
Shares Out
|
55,761,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-8,985,000 |
|
Investing Cash Flow
|
-3,000 |
| Market Analysis |
Market Cap
|
17,564,567 |
|
Price
|
1.90 |
|
BVPS
|
0.02 |
|
PB
|
83.11 |
|
EPS
|
-36.98 |
|
PS
|
57.03 |
|
FCF
|
-8,988,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view EVAX documents filed with the SEC.
EVAX Filings
Clear
